These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11229830)

  • 1. The inhibition of TNK-t-PA by C1-inhibitor.
    Sulikowski T; Patston PA
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):75-7. PubMed ID: 11229830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
    Huisman LG; van Griensven JM; Kluft C
    Thromb Haemost; 1995 Mar; 73(3):466-71. PubMed ID: 7667830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI
    J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor.
    Gaussem P; Grailhe P; Anglés-Cano E
    J Biol Chem; 1993 Jun; 268(16):12150-5. PubMed ID: 8505335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
    Gurewich V; Pannell R
    Thromb Haemost; 2009 Aug; 102(2):279-86. PubMed ID: 19652878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.
    Colucci M; Paramo JA; Collen D
    J Lab Clin Med; 1986 Jul; 108(1):53-9. PubMed ID: 3086473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
    Masson C; Angles-Cano E
    Biochem J; 1988 Nov; 256(1):237-44. PubMed ID: 3146972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interaction of C1-inhibitor with thrombin.
    Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
    Lucore CL; Sobel BE
    Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis.
    Pannell R; Kung W; Gurewich V
    J Thromb Haemost; 2007 May; 5(5):1047-54. PubMed ID: 17459007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA; Huang TC; Keyt BA; Alevriadou BR
    Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 inhibitor cross-linking by tissue transglutaminase.
    Hauert J; Patston PA; Schapira M
    J Biol Chem; 2000 May; 275(19):14558-62. PubMed ID: 10799541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF
    Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
    Gaussem P; Anglés-Cano E
    Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
    Jørgensen M; Bonnevie-Nielsen V
    Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.